Investments
3+ companies
Focus
Biotech, Digital Health
Vijay Pande is a General Partner focused on investing in transformative companies at the intersection of biotech, digital health, and artificial intelligence. With a deep expertise in life sciences and emerging technologies, Pande identifies and supports founders building solutions that leverage AI and computational approaches to address critical healthcare challenges. His investment portfolio includes notable companies such as Freenome, a molecular intelligence platform for early disease detection; Insitro, which applies machine learning to drug discovery and development; and Apeel Sciences, a leader in post-harvest food waste reduction through plant-derived coatings. Pande's investment thesis centers on companies that combine rigorous science with technological innovation to create meaningful impact in healthcare and sustainability. His track record demonstrates a commitment to backing visionary entrepreneurs who are reimagining how we prevent, diagnose, and treat disease while impro
Vijay Pande is a General Partner.
Vijay's investment focus spans Biotech, Digital Health, AI. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments in Vijay's portfolio include Apeel Sciences. These companies reflect a pattern of backing high-potential startups across their focus sectors.
Vijay Pande is a venture capital investor, focused on Biotech, Digital Health, AI.
Vijay Pande focuses on investments in Biotech, Digital Health, AI. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Vijay Pande's notable portfolio investments include Freenome, Insitro, Apeel Sciences. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.